EAM-2201
EAM-2201 is a synthetic cannabinoid that has been identified in various herbal smoking blends. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body.
Chemical Structure and Properties
EAM-2201 belongs to the class of indole-based synthetic cannabinoids. Its chemical structure is similar to other synthetic cannabinoids such as JWH-018 and AM-2201. The molecular formula of EAM-2201 is C24H22N2O, and its IUPAC name is 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
Pharmacology
EAM-2201 acts as a full agonist at the CB1 receptor and CB2 receptor, which are the primary receptors in the endocannabinoid system. These receptors are involved in various physiological processes including pain sensation, mood, and memory. The binding affinity of EAM-2201 to these receptors is high, making it a potent synthetic cannabinoid.
Legal Status
The legal status of EAM-2201 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, EAM-2201 is listed as a Schedule I controlled substance under the Controlled Substances Act.
Health Effects and Risks
The use of EAM-2201 has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and psychosis. Long-term use may lead to dependence and withdrawal symptoms. Due to its potency and the variability in the composition of herbal blends, the risk of overdose is significant.
Detection in Biological Samples
EAM-2201 can be detected in biological samples using various analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are used in forensic and clinical toxicology to identify the presence of synthetic cannabinoids in urine, blood, and other tissues.
See Also
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD